Design optimization for clinical trials in early-stage manifest Huntington's disease. (2017)

First Author: Frost C
Attributed to:  Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/mds.27122

PubMed Identifier: 28906031

Publication URI: http://europepmc.org/abstract/MED/28906031

Type: Journal Article/Review

Volume: 32

Parent Publication: Movement disorders : official journal of the Movement Disorder Society

Issue: 11

ISSN: 0885-3185